Published in
Elsevier, European Journal of Pharmaceutics and Biopharmaceutics, (137), p. 56-67, 2019
DOI: 10.1016/j.ejpb.2019.02.013
Links
Tools
Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice
Journal article published in 2019 by
Xue Luan,
Kamil Rahme,
Zhongcheng Cong,
Limei Wang,
Yifang Zou,
Yan He,
Hao Yang,
Justin D. Holmes,
Caitriona M. O'Driscoll,
Jianfeng Guo
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 